These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

222 related articles for article (PubMed ID: 33999634)

  • 1. The Role of Cyclodextrins against Interface-Induced Denaturation in Pharmaceutical Formulations: A Molecular Dynamics Approach.
    Rospiccio M; Arsiccio A; Winter G; Pisano R
    Mol Pharm; 2021 Jun; 18(6):2322-2333. PubMed ID: 33999634
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Binary inclusion complexes of diflunisal with β-cyclodextrin and hydroxypropyl-β-cyclodextrin: Preparation and characterization.
    Bashir M; Syed HK; Asghar S; Irfan M; Aslam N; Iqbal MS; Khan IU; Shah PA; Khan NR; Ahmad J; Saleem M; Asif M
    Pak J Pharm Sci; 2020 Sep; 33(5(Supplementary)):2307-2315. PubMed ID: 33832905
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Inclusion complex and nanoclusters of cyclodextrin to increase the solubility and efficacy of albendazole.
    Pacheco PA; Rodrigues LNC; Ferreira JFS; Gomes ACP; Veríssimo CJ; Louvandini H; Costa RLD; Katiki LM
    Parasitol Res; 2018 Mar; 117(3):705-712. PubMed ID: 29327323
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cytotoxicity of β-Cyclodextrins in Retinal Explants for Intravitreal Drug Formulations.
    Prajapati M; Christensen G; Paquet-Durand F; Loftsson T
    Molecules; 2021 Mar; 26(5):. PubMed ID: 33803405
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Diloxanide furoate binary complexes with β-, methyl-β-, and hydroxypropyl-β-cyclodextrins: inclusion mode, characterization in solution and in solid state and in vitro dissolution studies.
    Aloisio C; Longhi M
    Pharm Dev Technol; 2018 Sep; 23(7):723-731. PubMed ID: 28758845
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A detailed analysis of the influence of β-cyclodextrin derivates on the thermal denaturation of lysozyme.
    Starciuc T; Tabary N; Paccou L; Duponchel L; Guinet Y; Martel B; Hédoux A
    Int J Pharm; 2019 Jan; 554():1-13. PubMed ID: 30401625
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effect of hydroxypropyl beta-cyclodextrin on drug solubility in water-propylene glycol mixtures.
    Chang RK; Shojaei AH
    Drug Dev Ind Pharm; 2004 Mar; 30(3):297-302. PubMed ID: 15109029
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Molecular Dynamic Simulation Analysis on the Inclusion Complexation of Plumbagin with β-Cyclodextrin Derivatives in Aqueous Solution.
    Jitapunkul K; Toochinda P; Lawtrakul L
    Molecules; 2021 Nov; 26(22):. PubMed ID: 34833875
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Force Field Parameterization for the Description of the Interactions between Hydroxypropyl-β-Cyclodextrin and Proteins.
    Arsiccio A; Rospiccio M; Shea JE; Pisano R
    J Phys Chem B; 2021 Jul; 125(27):7397-7405. PubMed ID: 34210121
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Preparation and Biophysical Characterization of Quercetin Inclusion Complexes with β-Cyclodextrin Derivatives to be Formulated as Possible Nose-to-Brain Quercetin Delivery Systems.
    Manta K; Papakyriakopoulou P; Chountoulesi M; Diamantis DA; Spaneas D; Vakali V; Naziris N; Chatziathanasiadou MV; Andreadelis I; Moschovou K; Athanasiadou I; Dallas P; Rekkas DM; Demetzos C; Colombo G; Banella S; Javornik U; Plavec J; Mavromoustakos T; Tzakos AG; Valsami G
    Mol Pharm; 2020 Nov; 17(11):4241-4255. PubMed ID: 32986435
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Inhibition of agitation-induced aggregation of an IgG-antibody by hydroxypropyl-beta-cyclodextrin.
    Serno T; Carpenter JF; Randolph TW; Winter G
    J Pharm Sci; 2010 Mar; 99(3):1193-206. PubMed ID: 19774651
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Physicochemical characterization of berberine chloride: a perspective in the development of a solution dosage form for oral delivery.
    Battu SK; Repka MA; Maddineni S; Chittiboyina AG; Avery MA; Majumdar S
    AAPS PharmSciTech; 2010 Sep; 11(3):1466-75. PubMed ID: 20842541
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Improved Aqueous Solubility and Antihypercholesterolemic Activity of Ezetimibe on Formulating with Hydroxypropyl-β-Cyclodextrin and Hydrophilic Auxiliary Substances.
    Srivalli KM; Mishra B
    AAPS PharmSciTech; 2016 Apr; 17(2):272-83. PubMed ID: 26077622
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Influence of hydroxypropyl-beta-cyclodextrin complexation on piroxicam release from buccoadhesive tablets.
    Jug M; Bećirević-Laćan M
    Eur J Pharm Sci; 2004 Feb; 21(2-3):251-60. PubMed ID: 14757497
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Stability characterization, kinetics and mechanism of tacrolimus degradation in cyclodextrin solutions.
    Prajapati M; Eiriksson FF; Loftsson T
    Int J Pharm; 2020 Aug; 586():119579. PubMed ID: 32599134
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Surface adsorption and bulk aggregation of cyclodextrins by computational molecular dynamics simulations as a function of temperature: α-CD vs β-CD.
    Mixcoha E; Campos-Terán J; Piñeiro Á
    J Phys Chem B; 2014 Jun; 118(25):6999-7011. PubMed ID: 24884328
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Polysorbates versus Hydroxypropyl Beta-Cyclodextrin (HPβCD): Comparative Study on Excipient Stability and Stabilization Benefits on Monoclonal Antibodies.
    Zhang H; Hong S; Tan SSK; Peng T; Goh LYH; Lam KH; Chow KT; Gokhale R
    Molecules; 2022 Oct; 27(19):. PubMed ID: 36235038
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Interaction of [D-Trp6, Des-Gly10] LHRH ethylamide and hydroxy propyl beta-cyclodextrin (HPbetaCD): thermodynamics of interaction and protection from degradation by alpha-chymotrypsin.
    Koushik KN; Bandi N; Kompella UB
    Pharm Dev Technol; 2001 Nov; 6(4):595-606. PubMed ID: 11775960
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The role of polysorbate 80 and HPβCD at the air-water interface of IgG solutions.
    Serno T; Härtl E; Besheer A; Miller R; Winter G
    Pharm Res; 2013 Jan; 30(1):117-30. PubMed ID: 22910890
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Weak antibody-cyclodextrin interactions determined by quartz crystal microbalance and dynamic/static light scattering.
    Härtl E; Dixit N; Besheer A; Kalonia D; Winter G
    Eur J Pharm Biopharm; 2013 Nov; 85(3 Pt A):781-9. PubMed ID: 23685354
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.